
Kenox and Lactiga partner on sIgA therapies for immunodeficiency
Kenox Pharmaceuticals and Lactiga US have announced a strategic partnership to progress the development of new mucosal-targeted secretory IgA (sIgA) therapies, focusing on enhancing immunity for immunodeficient individuals. The partnership is backed by a …